Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects

underpinning intracellular targets for cardiorenal syndrome therapy

Feby Savira, Ruth Magaye, Yue Hua, Danny Liew, David Kaye, Tom Marwick, Bing Hui Wang

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Cardiorenal syndrome (CRS) remains a global health burden with a lack of definitive and effective treatment. Protein-bound uremic toxin (PBUT) overload has been identified as a non-traditional risk factor for cardiac, renal and vascular dysfunction due to significant albumin-binding properties, rendering these solutes non-dialyzable upon the state of irreversible kidney dysfunction. Although limited, experimental studies have investigated possible mechanisms in PBUT-mediated cardiac, renal and vascular effects. The ultimate aim is to identify relevant and efficacious targets that may translate beneficial outcomes in disease models and eventually in the clinic. This review will expand on detailed knowledge on mechanisms involved in detrimental effects of PBUT, specifically affecting the heart, kidney and vasculature, and explore potential effective intracellular targets to abolish their effects in CRS initiation and/or progression.

Original languageEnglish
Pages (from-to)34-49
Number of pages16
JournalToxicology Letters
Volume308
DOIs
Publication statusPublished - 15 Jun 2019

Keywords

  • Cardiorenal syndrome
  • Intracellular signaling pathway
  • Pharmacological targets
  • Protein-bound uremic toxin

Cite this

@article{c73fe543407a491ca9395f164df8fb7f,
title = "Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy",
abstract = "Cardiorenal syndrome (CRS) remains a global health burden with a lack of definitive and effective treatment. Protein-bound uremic toxin (PBUT) overload has been identified as a non-traditional risk factor for cardiac, renal and vascular dysfunction due to significant albumin-binding properties, rendering these solutes non-dialyzable upon the state of irreversible kidney dysfunction. Although limited, experimental studies have investigated possible mechanisms in PBUT-mediated cardiac, renal and vascular effects. The ultimate aim is to identify relevant and efficacious targets that may translate beneficial outcomes in disease models and eventually in the clinic. This review will expand on detailed knowledge on mechanisms involved in detrimental effects of PBUT, specifically affecting the heart, kidney and vasculature, and explore potential effective intracellular targets to abolish their effects in CRS initiation and/or progression.",
keywords = "Cardiorenal syndrome, Intracellular signaling pathway, Pharmacological targets, Protein-bound uremic toxin",
author = "Feby Savira and Ruth Magaye and Yue Hua and Danny Liew and David Kaye and Tom Marwick and Wang, {Bing Hui}",
year = "2019",
month = "6",
day = "15",
doi = "10.1016/j.toxlet.2019.03.002",
language = "English",
volume = "308",
pages = "34--49",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier",

}

Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects : underpinning intracellular targets for cardiorenal syndrome therapy. / Savira, Feby; Magaye, Ruth; Hua, Yue; Liew, Danny; Kaye, David; Marwick, Tom; Wang, Bing Hui.

In: Toxicology Letters, Vol. 308, 15.06.2019, p. 34-49.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects

T2 - underpinning intracellular targets for cardiorenal syndrome therapy

AU - Savira, Feby

AU - Magaye, Ruth

AU - Hua, Yue

AU - Liew, Danny

AU - Kaye, David

AU - Marwick, Tom

AU - Wang, Bing Hui

PY - 2019/6/15

Y1 - 2019/6/15

N2 - Cardiorenal syndrome (CRS) remains a global health burden with a lack of definitive and effective treatment. Protein-bound uremic toxin (PBUT) overload has been identified as a non-traditional risk factor for cardiac, renal and vascular dysfunction due to significant albumin-binding properties, rendering these solutes non-dialyzable upon the state of irreversible kidney dysfunction. Although limited, experimental studies have investigated possible mechanisms in PBUT-mediated cardiac, renal and vascular effects. The ultimate aim is to identify relevant and efficacious targets that may translate beneficial outcomes in disease models and eventually in the clinic. This review will expand on detailed knowledge on mechanisms involved in detrimental effects of PBUT, specifically affecting the heart, kidney and vasculature, and explore potential effective intracellular targets to abolish their effects in CRS initiation and/or progression.

AB - Cardiorenal syndrome (CRS) remains a global health burden with a lack of definitive and effective treatment. Protein-bound uremic toxin (PBUT) overload has been identified as a non-traditional risk factor for cardiac, renal and vascular dysfunction due to significant albumin-binding properties, rendering these solutes non-dialyzable upon the state of irreversible kidney dysfunction. Although limited, experimental studies have investigated possible mechanisms in PBUT-mediated cardiac, renal and vascular effects. The ultimate aim is to identify relevant and efficacious targets that may translate beneficial outcomes in disease models and eventually in the clinic. This review will expand on detailed knowledge on mechanisms involved in detrimental effects of PBUT, specifically affecting the heart, kidney and vasculature, and explore potential effective intracellular targets to abolish their effects in CRS initiation and/or progression.

KW - Cardiorenal syndrome

KW - Intracellular signaling pathway

KW - Pharmacological targets

KW - Protein-bound uremic toxin

UR - http://www.scopus.com/inward/record.url?scp=85063750489&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2019.03.002

DO - 10.1016/j.toxlet.2019.03.002

M3 - Review Article

VL - 308

SP - 34

EP - 49

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

ER -